Now showing items 1-3 of 3

    • Overactive bladder : Is there a link to the metabolic syndrome in men? 

      Kirby, M.; Wagg, A.; Cardozo, L.; Chapple, C.; Castro-Diaz, D.; de Ridder, D.; Espuna-Pons, M.; Haab, F.; Kelleher, C.; Kolbl, H.; Milsom, I.; van Kerrebroeck, P.; Vierhout, M.; Salvatore, S.; Tubaro, A. (2010)
      It is becoming increasingly clear that a variety of metabolic, cardiovascular, and endocrine factors contribute to male pelvic health. In particular, a growing body of evidence suggests a relationship between lower urinary ...
    • Pelvic organ prolapse and overactive bladder 

      de Boer, T.A.; Salvatore, S.; Cardozo, L.; Chapple, C.; Kelleher, C.; van Kerrebroeck, P.; Kirby, M.; Koelbl, H.; Espuna-Pons, M.; Milsom, I.; Tubaro, A.; Wagg, A.; Vierhout, M. (2010)
      In this review we try to shed light on the following questions: How frequently are symptoms of overactive bladder (OAB) and is detrusor overactivity (DO) present in patients with pelvic organ prolapse (POP) and is there a ...
    • A review of adherence to drug therapy in patients with overactive bladder 

      Basra, R.K.; Wagg, A.; Chapple, C.; Cardozo, L.; Castro-Diaz, D.; Pons, M.E.; Kirby, M.; Milsom, I.; Vierhout, M.; van Kerrebroeck, P.; Kelleher, C. (2008)
      Drug therapy for overactive bladder (OAB) is associated with improvements in symptoms and quality of life, but the short- and long-term adherence and persistence is suboptimal. In this review we outline methods of measuring, ...